Roth L M, Gersell D J, Ulbright T M
Department of Pathology, Indiana University School of Medicine, Indianapolis.
Int J Gynecol Pathol. 1993 Apr;12(2):128-33. doi: 10.1097/00004347-199304000-00007.
Brenner tumor variants--such as metaplastic, proliferating, and low-malignant-potential (three categories recently designated as intermediate Brenner tumors)--and malignant Brenner tumors are unusual tumors presenting problems in classification. DNA ploidy and S-phase reflect the intermediate status of metaplastic, proliferating, and low-malignant-potential Brenner tumors. The category of "transitional cell carcinoma of the ovary" has been proposed for those primary ovarian carcinomas in which definite urothelial features are present, but no benign, metaplastic, and/or proliferating Brenner tumor is identified. Two subtypes have been described, the papillary and the malignant Brenner-like types. These tumors are more aggressive than malignant Brenner tumors, but they appear to respond better to chemotherapy than other types of ovarian epithelial cancer.
勃勒纳瘤变体——如化生型、增殖型和低恶性潜能型(最近被指定为中间型勃勒纳瘤的三类)以及恶性勃勒纳瘤——是分类存在问题的不常见肿瘤。DNA倍体和S期反映了化生型、增殖型和低恶性潜能型勃勒纳瘤的中间状态。对于那些存在明确尿路上皮特征但未发现良性、化生型和/或增殖型勃勒纳瘤的原发性卵巢癌,已提出“卵巢移行细胞癌”这一类别。已描述了两种亚型,即乳头状和恶性勃勒纳瘤样型。这些肿瘤比恶性勃勒纳瘤更具侵袭性,但它们似乎比其他类型的卵巢上皮癌对化疗反应更好。